Human-Human Hybridoma Monoclonal Antibodies in Diagnosis and Treatment of Neoplastic Disease

  • Henry S. Kaplan
  • Lennart Olsson
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)


A new era in immunology was introduced by Köhler and Milstein (1975, 1976) when they devised a method for the production of mouse “hybridomas” capable of secreting monoclonal antibodies of predefined antigenic specificity. Immunologists were liberated from the constraints and difficulties previously associated with the preparation and use of heteroantisera, since the clonal selection and immortality of hybridoma cell lines assure the monoclonality, monospecificity, and permanent availability of their antibody products. However, although monoclonal antibodies of murine or other rodent origin have been extraordinarily powerful new reagents in laboratory investigations, their clinical use is likely to be severely limited by the fact that they are foreign proteins. Human immunoglobulin-producing cells have been fused to mouse myeloma cells to generate chimeric hybridomas (Schwaber, 1975; Levy and Dilley, 1978). Although there have been rare instances in which long-term, stable production of human antibody has thus been achieved (Schlom et al., 1980), most such hybrids have tended to be highly unstable due to the selective loss of human chromosomes. An alternative approach to the generation of antibody-producing human lymphocyte cell lines has involved the transformation of human B-lymphocytes with Epstein-Barr virus (EBV) (Steinitz et al., 1977; Zurawski et al., 1978; Koskimies, 1979) but this method appears to be of limited practical usefulness because the cultures tend to cease antibody production after a variable period (Zurawski et al., 1978).


Myeloma Cell Human Monoclonal Antibody Myeloma Cell Line Murine Monoclonal Antibody Murine Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bankert, R.B., DesSoye, D. and Powers, L., 1980, Antigen-promoted cell fusion: antigen-coated myeloma cells fuse with antigen-reactive spleen cells, Transpl. Proc., 12: 443.Google Scholar
  2. Böyum, A., 1968, Separation of leucocytes from blood and bone marrow, Scand. J. Clin. Lab. Invest. 21, Suppl. 97: 77.Google Scholar
  3. Cunningham, A.J., and Szenberg, A, 1968, Further improvements in the plaque technique for detecting single antibody-producing cells, Immunology, 14: 599.Google Scholar
  4. Eltringham, J.R., and Kaplan, H.S., 1973, Impaired delayed hypersensitivity responses in 154 patients with Hodgkin’s disease, Natl. Cancer Inst. Monogr. 36: 107.Google Scholar
  5. Epstein, A.L., and Kaplan, H.S., 1974, Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas, Cancer 34: 1851.CrossRefGoogle Scholar
  6. Glatstein, E., Guernsey, J.M., Rosenberg, S.A., and Kaplan, H.S., 1969, The value of laparotomy and splenectomy in the staging of Hodgkin’s disease, Cancer, 24: 709.CrossRefGoogle Scholar
  7. Hoffman, M.K., 1980, Antigen-specific induction and regulation of antibody synthesis in cultures of human peripheral blood mononuclear cells, Proc. Nat. Acad. Sci. USA, 77: 1139.CrossRefGoogle Scholar
  8. Iscove, N.N., and Melchers, F., 1978, Complete replacement of serum by albumin, transferrin and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes, J. Exp. Med., 147: 923.CrossRefGoogle Scholar
  9. Jerne, N.K., and Nordin, A.A., 1963, Plaque formation in agar by single antibody-producing cells, Science, 140: 405.CrossRefGoogle Scholar
  10. Kaplan, H.S., Gartner, S., Goodenow, R.S., and Bieber, M.M., 1979, Biology and virology of the human malignant lymphomas; 1st Milford D. Schultz lecture, Cancer, 43: 1.CrossRefGoogle Scholar
  11. Kaplan, H.S., Goodenow, R.S., Epstein, A.L., Gartner, S., Decleve, A., and Rosenthal, P.N., 1977, Isolation of a C-type RNA virus from an established human histiocytic lymphoma cell line, Proc. Nat. Acad. Sci. USA 74: 2564.CrossRefGoogle Scholar
  12. Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256: 495.CrossRefGoogle Scholar
  13. Köhler, G., and Milstein, C., 1976, Derivation of specific antibody- producing tissue culture and tumor lines by cell fusion, Eur. J. Immunol., 6: 511.CrossRefGoogle Scholar
  14. Koskimies, S., 1979, Human lymphoblastoid cell line producing specific antibody against Rh-antigen, Scand. J. Immunol., 10: 371 (abst.).Google Scholar
  15. Levy, R., and Dilley, J., 1978, Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization, Proc. Nat. Acad. Sci. USA, 75: 2411.CrossRefGoogle Scholar
  16. Nilsson, K., Bennich, H., Johansson, S.G.O., and Ponton, J., 1970, Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient, Clin. Exp. Immunol., 7: 477.Google Scholar
  17. Olsson, L, and Kaplan, H.S., 1980, Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity, Proc. Nat. Acad. Sci. USA, 77: 5429.CrossRefGoogle Scholar
  18. Parks, D.R., Bryan, V.M., Oi, V.T., and Herzenberf, L.A., 1979, Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter, Proc. Natl. Acad. Sci. USA, 76: 1962.CrossRefGoogle Scholar
  19. Schlom, J., Wunderlich, D., and Teramoto, Y.A., 1980, Generation of human monoclonal antibodies reactive with human mammary carcinoma cells, Proc. Nat. Acad. Sci. USA, 77: 6841.CrossRefGoogle Scholar
  20. Schneiderman, S., Farber, J.L., and Baserga, R., 1979, A simple method for decreasing the toxicity of polyethylene glycol in mammalian cell hybridization, Somatic Cell Genetics, 5: 263.CrossRefGoogle Scholar
  21. Schwaber, J., 1975, Immunoglobulin production by a human-mouse somatic cell hybrid, Exper. Cell Res., 93: 343.CrossRefGoogle Scholar
  22. Sharon, J., Morrison, S.L., and Kabat, E.A., 1980, Formation of hybridoma clones in soft agarose: effect of pH and of medium, Somatic Cell Genet., 6: 435.CrossRefGoogle Scholar
  23. Steinitz, M., Klein, G., Koskimies, S., and Makeia, O., 1977, EB virus-induced B lymphocyte cell lines producing specific antibody, Nature, 269: 420.CrossRefGoogle Scholar
  24. Zurawski, V.R., Jr., Haber, E., and Black, P.H., 1978, Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines, Science, 199: 1439.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Henry S. Kaplan
    • 1
  • Lennart Olsson
    • 1
  1. 1.Cancer Biology Research Laboratory Department of RadiologyStanford University School of MedicineStanfordUSA

Personalised recommendations